I strongly believe that there is so much going on behind
I strongly believe that there is so much going on behind the scene at IPIX that shareholders would be amazed.
The fierce gambits it has had to fight for the past number of years, the 24/7 chat board paid antagonizers it has seen, the strength of its products, the need of so many BPs to replenish their pipelines, the fact that our mgt knows what we own and will not give it away, the knowledge of our medical team in recognizing the myriad indications and spheres of medicine each product could attack, and the total silence we have had for most of this year as to negotiations, etc are the basis for my beliefs.
I agree that right now it would seem OM or OM/IBD are the indications on the table for partnering immediately, but the sale of a whole platform or even the whole company wouldn't take me by surprise as nobody has a clue as to what monies have been discussed with the major players, if the mgt team wants to work deals for the next number of years, or if they are at a point where a nice chunk of change to back out of the picture and let a BP throw their entire weight behind getting these products to market as soon as possible.
The possibilities are many, the options tantalizing, and all lead to major success for IPIX. The only question is how soon and for how much.
8
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...
Continue Reading
Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...
Continue Reading
Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...
Continue Reading
NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...
Continue Reading
Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...
Continue Reading
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...
Continue Reading
JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...
Continue Reading
The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...
Continue Reading
Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...
Continue Reading
Top 5 Most Recently Viewed Articles
Thermo Fisher Scientific's Q3 Performance Overview Thermo Fisher Scientific Inc. (NYSE: TMO) recently shared its financial results for the third quarter, revealing revenue of approximately $10.59 billion. While this figure is nearly unchanged compared to the previous year, it slightly fell short of the anticipated consensus of $10.64 billion. Segment Performance Analysis...
Continue Reading
Examining Retail Earnings and Consumer Sentiment This week marks a significant moment for the retail industry as key players prepare to unveil their earnings reports. The anticipation builds as we await insights from top retailers this week. Recently, the U.S. Census Bureau shared insights on retail sales, revealing mixed results. While the figures aren’t staggering,...
Continue Reading
Surge Copper Corp. Grants Equity-Based Incentives Surge Copper Corp. (TSXV: SURG) is excited to announce a significant development in its incentive program aimed at enhancing team engagement. As part of its Share Compensation Plan, the Company has awarded a substantial number of long-term equity-based incentive awards to its dedicated employees and executives. Details of...
Continue Reading
Stepan Company Welcomes New Vice President and CFO Stepan Company, a leader in the specialty and intermediate chemicals sector, proudly announces the appointment of Ruben Velasquez as their new Vice President and Chief Financial Officer. This significant move signifies Stepan's commitment to strengthening its financial leadership. Mr. Velasquez's role becomes effective...
Continue Reading
Award-Winning Leadership in Oncology In the world of oncology, it's not every day that you see a young leader make waves like Kiana Mehring from Florida Cancer Specialists & Research Institute (FCS). This lady just nabbed the 40 Under 40 in Cancer Award, shining a light on the complicated dance of payer strategies and patient care. Recognizing folks like Mehring, who’s...
Continue Reading